These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 10725990)

  • 1. Outcome of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome in Japan.
    Mori Y; Wada H; Tamaki S; Minami N; Shiku H; Ihara T; Omine M; Kakisita E
    Clin Appl Thromb Hemost; 1999 Apr; 5(2):110-2. PubMed ID: 10725990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Differentiation of Shiga Toxin-Associated Hemolytic Uremic Syndrome in Critically Ill Adults With Thrombotic Microangiopathy Syndromes.
    Joseph A; Rafat C; Zafrani L; Mariani-Kurkdjian P; Veyradier A; Hertig A; Rondeau E; Mariotte E; Azoulay E
    Crit Care Med; 2018 Sep; 46(9):e904-e911. PubMed ID: 29979220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome in pregnancy: review of 11 cases.
    Egerman RS; Witlin AG; Friedman SA; Sibai BM
    Am J Obstet Gynecol; 1996 Oct; 175(4 Pt 1):950-6. PubMed ID: 8885753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of pregnancy with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
    George JN
    Curr Opin Hematol; 2003 Sep; 10(5):339-44. PubMed ID: 12913787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Furlan M; Robles R; Galbusera M; Remuzzi G; Kyrle PA; Brenner B; Krause M; Scharrer I; Aumann V; Mittler U; Solenthaler M; Lämmle B
    N Engl J Med; 1998 Nov; 339(22):1578-84. PubMed ID: 9828245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catastrophic presentation of a patient with combined NMOSD and thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: a case report.
    Okhovat AA; Ansari B; Rezaali S; Altintas A; Naser Moghadasi A
    Acta Neurol Belg; 2017 Sep; 117(3):757-759. PubMed ID: 27757811
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of thrombotic microangiopathies].
    Debourdeau P; Zammit C; Souleau B; Védrine L; Farge-Bancel D
    Ann Med Interne (Paris); 1999 Sep; 150(5):374-87. PubMed ID: 10544747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved survival with plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
    Lara PN; Coe TL; Zhou H; Fernando L; Holland PV; Wun T
    Am J Med; 1999 Dec; 107(6):573-9. PubMed ID: 10625026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Southwestern Internal Medicine Conference: Shiga-like toxins in hemolytic-uremic syndrome and thrombotic thrombocytopenic purpura.
    Hofmann SL
    Am J Med Sci; 1993 Dec; 306(6):398-406. PubMed ID: 8266983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura with fresh frozen plasma and plasma exchange.
    Thysell H; Oxelius VA; Norlin M
    Acta Med Scand; 1982; 212(5):285-8. PubMed ID: 6891171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological characteristics and outcome of Chinese patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: a 9-year retrospective study.
    Zhang W; Shi H; Ren H; Shen PY; Pan XX; Li X; Chen YX; Xu YW; Chen XN; Zhu P; Chen N
    Nephron Clin Pract; 2009; 112(3):c177-83. PubMed ID: 19439988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome.
    Miller DP; Kaye JA; Shea K; Ziyadeh N; Cali C; Black C; Walker AM
    Epidemiology; 2004 Mar; 15(2):208-15. PubMed ID: 15127914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iloprost in the treatment of thrombotic microangiopathy: report of thirteen cases.
    Sagripanti A; Carpi A; Rosaia B; Morelli E; Innocenti M; D'Acunto G; Nicolini A
    Biomed Pharmacother; 1996; 50(8):350-6. PubMed ID: 8952854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-examination of 30-day survival and relapse rates in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
    Bittencourt CE; Ha JP; Maitta RW
    PLoS One; 2015; 10(5):e0127744. PubMed ID: 26000799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Plasma exchange therapy in patients with thrombotic thrombocytopenic purpura/hemolytic uremic syndrome].
    Ikeda Y; Kikuchi M
    Nihon Rinsho; 1992 Jan; 50 Suppl():293-7. PubMed ID: 1578694
    [No Abstract]   [Full Text] [Related]  

  • 16. The renal manifestations and outcome of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in adults.
    Conlon PJ; Howell DN; Macik G; Kovalik EC; Smith SR
    Nephrol Dial Transplant; 1995; 10(7):1189-93. PubMed ID: 7478122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of bacterial cytotoxins in hemolytic uremic syndrome and thrombotic thrombocytopenic purpura.
    Ashkenazi S
    Annu Rev Med; 1993; 44():11-8. PubMed ID: 8476235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients.
    Bell WR; Braine HG; Ness PM; Kickler TS
    N Engl J Med; 1991 Aug; 325(6):398-403. PubMed ID: 2062331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two novel ADAMTS13 gene mutations in thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome (TTP/HUS).
    Licht C; Stapenhorst L; Simon T; Budde U; Schneppenheim R; Hoppe B
    Kidney Int; 2004 Sep; 66(3):955-8. PubMed ID: 15327386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: a concise review.
    Dlott JS; Danielson CF; Blue-Hnidy DE; McCarthy LJ
    Ther Apher Dial; 2004 Apr; 8(2):102-11. PubMed ID: 15255125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.